Suchergebnisse - (Subject:"Ritonavir")

PubPharm (9.308)

21

Nirmatrelvir and ritonavir combination against COVID-19 caused by omicron BA.2.2 in the elderly : A single-center large observational study

enthalten in: Immunity, inflammation and disease | 2024

von Chen, C. | Li, R. | Xing, S. | +5

22

Safety, efficacy, and pharmacokinetics of nirmatrelvir and ritonavir in patients with severe COVID-19 and renal impairment : A case report

enthalten in: Heliyon | 2024

von Zheng, R. | Fan, X. | Zhou, F. | +7

23

Question : How Should I Monitor and Adjust the Clozapine Dose for My Patients Who Develop COVID and Could Benefit From Nirmatrelvir/Ritonavir?

enthalten in: Journal of clinical psychopharmacology | 2024

von de Leon, J.

24

Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health system

enthalten in: Scientific reports | 2024

von Malden, D. | McLaughlin, J. | Hong, V. | +8

25

Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease

enthalten in: Expert review of anti-infective therapy | 2024

von Chen, C. | Huang, C. | Wu, J. | +12

26

Paxlovid for nonhospitalized patients with COVID-19

enthalten in: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine | 2024

von Johari, F. | Verma, R.

27

Recurrent and persistent fever after SARS-CoV-2 infection in patients with follicular lymphoma : A case series

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Huang, L. | Tong, X. | Cui, J. | +8

28

Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19 : a causal inference approach

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Cheung, Y. | Lau, E. | Yin, G. | +4

29

Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease

enthalten in: Virology journal | 2024

von Colaneri, M. | Scaglione, G. | Fassio, F. | +20

30

Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease

enthalten in: Virology journal | 2024

von Colaneri, M. | Scaglione, G. | Fassio, F. | +20